156 related articles for article (PubMed ID: 8811092)
1. Mutational analysis of the human nucleotide excision repair gene ERCC1.
Sijbers AM; van der Spek PJ; Odijk H; van den Berg J; van Duin M; Westerveld A; Jaspers NG; Bootsma D; Hoeijmakers JH
Nucleic Acids Res; 1996 Sep; 24(17):3370-80. PubMed ID: 8811092
[TBL] [Abstract][Full Text] [Related]
2. Role of the nucleotide excision repair gene ERCC1 in formation of recombination-dependent rearrangements in mammalian cells.
Sargent RG; Meservy JL; Perkins BD; Kilburn AE; Intody Z; Adair GM; Nairn RS; Wilson JH
Nucleic Acids Res; 2000 Oct; 28(19):3771-8. PubMed ID: 11000269
[TBL] [Abstract][Full Text] [Related]
3. The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif.
Enzlin JH; Schärer OD
EMBO J; 2002 Apr; 21(8):2045-53. PubMed ID: 11953324
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of DNA repair nuclease ERCC1-XPF promotes prostate cancer progression in a tissue recombination model.
Matoka DJ; Yao V; Harya DS; Gregg JL; Robinson AR; Niedernhofer LJ; Parwani AV; Maier C; Bacich DJ
Prostate; 2012 Aug; 72(11):1214-22. PubMed ID: 22212909
[TBL] [Abstract][Full Text] [Related]
5. Multiple DNA repair pathways prevent acetaldehyde-induced mutagenesis in yeast.
Porcher L; Vijayraghavan S; McCollum J; Mieczkowski PA; Saini N
bioRxiv; 2024 Jan; ():. PubMed ID: 38260495
[TBL] [Abstract][Full Text] [Related]
6. Modulation of ERCC1-XPF Heterodimerization Inhibition
Weilbeer C; Jay D; Donnelly JC; Gentile F; Karimi-Busheri F; Yang X; Mani RS; Yu Y; Elmenoufy AH; Barakat KH; Tuszynski JA; Weinfeld M; West FG
Front Oncol; 2022; 12():819172. PubMed ID: 35372043
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of nucleotide excision repair machinery.
D'Souza A; Blee AM; Chazin WJ
Biochem Soc Trans; 2022 Feb; 50(1):375-386. PubMed ID: 35076656
[TBL] [Abstract][Full Text] [Related]
8. ERCC1 mutations impede DNA damage repair and cause liver and kidney dysfunction in patients.
Apelt K; White SM; Kim HS; Yeo JE; Kragten A; Wondergem AP; Rooimans MA; González-Prieto R; Wiegant WW; Lunke S; Flanagan D; Pantaleo S; Quinlan C; Hardikar W; van Attikum H; Vertegaal ACO; Wilson BT; Wolthuis RMF; Schärer OD; Luijsterburg MS
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33315086
[TBL] [Abstract][Full Text] [Related]
9. Suppression effect of N-acetylcysteine on bone loss in ovariectomized mice.
Zhou X; Wang Z; Ni Y; Yu Y; Wang G; Chen L
Am J Transl Res; 2020; 12(3):731-742. PubMed ID: 32269708
[TBL] [Abstract][Full Text] [Related]
10. Fanconi anemia pathway as a prospective target for cancer intervention.
Liu W; Palovcak A; Li F; Zafar A; Yuan F; Zhang Y
Cell Biosci; 2020; 10():39. PubMed ID: 32190289
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer.
Jager M; Blokzijl F; Kuijk E; Bertl J; Vougioukalaki M; Janssen R; Besselink N; Boymans S; de Ligt J; Pedersen JS; Hoeijmakers J; Pothof J; van Boxtel R; Cuppen E
Genome Res; 2019 Jul; 29(7):1067-1077. PubMed ID: 31221724
[TBL] [Abstract][Full Text] [Related]
12. High/positive expression of ERCC1 predicts poor treatment response and survival prognosis in nasopharyngeal carcinoma: A systematic meta-analysis from 21 studies.
Yang L; Wei W; Zhou L; Wang J; Hu G
Medicine (Baltimore); 2019 May; 98(21):e15641. PubMed ID: 31124943
[TBL] [Abstract][Full Text] [Related]
13. Transcription coupled repair and biased insertion of human retrotransposon L1 in transcribed genes.
Servant G; Streva VA; Deininger PL
Mob DNA; 2017; 8():18. PubMed ID: 29225704
[TBL] [Abstract][Full Text] [Related]
14. Disruption of DNA repair in cancer cells by ubiquitination of a destabilising dimerization domain of nucleotide excision repair protein ERCC1.
Yang L; Ritchie AM; Melton DW
Oncotarget; 2017 Aug; 8(33):55246-55264. PubMed ID: 28903417
[TBL] [Abstract][Full Text] [Related]
15. Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer.
Jacobsen F; Taskin B; Melling N; Sauer C; Wittmer C; Hube-Magg C; Kluth M; Simon R; Pehrke D; Beyer B; Steuber T; Thederan I; Sauter G; Schlomm T; Wilczak W; Möller K; Weidemann SA; Burdak-Rothkamm S
BMC Cancer; 2017 Jul; 17(1):504. PubMed ID: 28747165
[TBL] [Abstract][Full Text] [Related]
16. XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.
Lehmann J; Seebode C; Smolorz S; Schubert S; Emmert S
Cell Mol Life Sci; 2017 Jun; 74(11):2081-2094. PubMed ID: 28130555
[TBL] [Abstract][Full Text] [Related]
17. The Nucleotide Excision Repair Pathway Limits L1 Retrotransposition.
Servant G; Streva VA; Derbes RS; Wijetunge MI; Neeland M; White TB; Belancio VP; Roy-Engel AM; Deininger PL
Genetics; 2017 Jan; 205(1):139-153. PubMed ID: 28049704
[TBL] [Abstract][Full Text] [Related]
18. Single-stranded DNA Binding by the Helix-Hairpin-Helix Domain of XPF Protein Contributes to the Substrate Specificity of the ERCC1-XPF Protein Complex.
Das D; Faridounnia M; Kovacic L; Kaptein R; Boelens R; Folkers GE
J Biol Chem; 2017 Feb; 292(7):2842-2853. PubMed ID: 28028171
[TBL] [Abstract][Full Text] [Related]
19. The Cerebro-oculo-facio-skeletal Syndrome Point Mutation F231L in the ERCC1 DNA Repair Protein Causes Dissociation of the ERCC1-XPF Complex.
Faridounnia M; Wienk H; Kovačič L; Folkers GE; Jaspers NG; Kaptein R; Hoeijmakers JH; Boelens R
J Biol Chem; 2015 Aug; 290(33):20541-55. PubMed ID: 26085086
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
